Halofuginone hydrobromide
CAS: 64924-67-0
Ref. IN-DA00E8T7
| 1g | Descontinuado | ||
| 5mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado |
Informação sobre produto
Nome:
Halofuginone hydrobromide
Sinónimos:
- [u'7-bromo-6-chlorofebrifugine', u'halofuginone', u'halofunginone', u'Stenorol', u'64924-67-0', u'Stenorol', u'Tempostatin', u'NSC-713205', u'7-Bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one hydrobromide', u'Ru 19110', u'RU-19110', u'7-Bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one hydrobromid', u'Halofuginone hydrobromide (USAN)', u'Stenorol (TN)', u'NSC713205', u'AC1L8G9H', u'AC1Q23BC', u'SCHEMBL608785', u'CHEMBL1969752', u'CTK5C1868', u'HY-N1584A', u'4(3H)-Quinazolinone,7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-,hydrobromide (1:1), rel-', u'ANW-44902', u'HT-100', u'AKOS015920268', u'API0016607', u'SB19687', u'7-bromo-6-chloro-3-{3-[(2s,3r)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3h)-one hydrobromide(1:1)', u'BR-72845', u'AX8187929', u'TC-133647', u'CS-0081860', u'FT-0669097', u'D04413', u'924H670', u'Q-201183', u'UNII-PTC2969MV1 component SJUWEPZBTXEUMU-LDXVYITESA-N', u'Halofuginone hydrobromide, VETRANAL(TM), analytical standard', u'4(3H)-Quinazolinone,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel-', u'7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one hydrobromide', u'trans-( inverted exclamation markA)-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4(3H)-quinazolinone monohydrobromide', u'Halofunginone', u'Halofuginone', u'Halofuginonehydrobromide', u'UNII-PTC2969MV1', u'Halofuginone hydrobromide [USAN]', u'AR-1H3207', u'CID400771', u'C16-H17-Br-Cl-N3-O3.Br-H', u'Halofuginone HBr ((2R,3S) and (2S,3R) mixture)', u'(+-)-trans-7-Bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4(3H)-quinazolinone monohydrobromide', u'(+/-)-trans-7-Bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4(3H)-quinazolinone monohydrobromide', u'4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, hydrobromide, trans-(+/-)-', u'65405-66-5']
- 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-, monohydrobromide, trans-
- 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, hydrobromide (1:1), rel-
- 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel-
- 7-Bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one hydrobromide
- 7-bromo-6-chloro-3-{3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one hydrobromide
- Ru 19110
- Stenorol
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
495.5934
Fórmula:
C16H18Br2ClN3O3
Pureza:
98%
Cor/forma:
Solid
InChI:
InChI=1S/C16H17BrClN3O3.BrH/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14;/h5-6,8,14-15,19,23H,1-4,7H2;1H/t14-,15+;/m0./s1
Chave InChI:
SJUWEPZBTXEUMU-LDXVYITESA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
